Federal Register #DEA-1773

DEA Review of Eli-Elsohly Laboratories Application for Bulk Manufacturing of Controlled Substances

The Drug Enforcement Administration (DEA), part of the Department of Justice, is reviewing an application from Eli-Elsohly Laboratories for registration as a bulk manufacturer of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - Applicant/OEM: - Eli-Elsohly Laboratories - Products/Controlled Substances Requested: - Marihuana Extract (7350) - Marihuana (7360) - Tetrahydrocannabinols (7370) - Dihydromorphine (9145) - Amphetamine (1100) - Methamphetamine (1105) - Cocaine (9041) - Codeine (9050) - Dihydrocodeine (9120) - Oxycodone (9143) - Ecgonine (9180) - Thebaine (9333) - Intended Use: - Manufacture for product development reference standards - Isolation of certain substances from Marihuana Extract - Unique Requirements: - No cultivation of Marihuana (7360) is authorized under this registration - DEA is soliciting public comments or objections regarding the registration

Description

Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The application includes substances such as Marihuana Extract, Marihuana, Tetrahydrocannabinols, Dihydromorphine, Amphetamine, Methamphetamine, Cocaine, Codeine, Dihydrocodeine, Oxycodone, Ecgonine, and Thebaine. The company plans to manufacture these substances for product development reference standards and will isolate some substances from Marihuana Extract. Comments or objections to the registration must be submitted by November 23, 2026.

View original listing